<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131229">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02046577</url>
  </required_header>
  <id_info>
    <org_study_id>13-116</org_study_id>
    <secondary_id>Fonis SA13I20173</secondary_id>
    <nct_id>NCT02046577</nct_id>
  </id_info>
  <brief_title>Study of Vitamin D for the Prevention of Acute Respiratory Infections in Children</brief_title>
  <official_title>A Randomized, Double-blind, Controlled Trial of Vitamin D for the Prevention of Acute Respiratory Infections in Children Aged 18 to 36 Months in Santiago, Coyhaique and Punta Arenas, Chile</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pontificia Universidad Catolica de Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondo Nacional de Investigación y Desarrollo en Salud, Chile</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratorio Pasteur</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Pontificia Universidad Catolica de Chile</source>
  <oversight_info>
    <authority>Chile: Comisión Nacional de Investigación Científica y Tecnológica</authority>
    <authority>Chile: Instituto de Salud Pública</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to determine whether weekly oral vitamin D supplementation
      is effective to prevent acute respiratory tract infections in children. The hypothesis of
      the study is that vitamin D supplementation reduces the incidence and severity of acute
      respiratory tract infections in children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute respiratory tract infections (ARTIs) are associated with high levels of morbidity and
      socioeconomic impact, particularly affecting young children. Observational studies have
      shown an association between vitamin D (VD) deficiency and higher incidence and severity of
      respiratory infections. Chile has a high prevalence of VD deficiency, particularly in the
      southern regions of the country. The objective of this study is to evaluate the safety and
      efficacy of oral VD supplementation to decrease the incidence of ARTIs in 275 preschool
      children. A randomized, placebo-controlled, double-blind study will be performed in
      Santiago, Coyhaique and Punta Arenas. Children aged 18 to 36 months will be given weekly
      oral 5600 IU of vitamin D3 (VD3), 11200 IU of VD3, or placebo doses during 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Incidence of acute respiratory tract infections</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalizations due to acute respiratory tract infections</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum cathelicidin levels</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Baseline and after 6 months measurement of serum cathelicidin levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>serum 25-hydroxyvitamin D levels</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Baseline and after 6 months measurement of serum 25-hydroxyvitamin D levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Viral etiology of ARTIs</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Specific virological etiology of ARTIs will be evaluated by polymerase chain reaction in children with febrile ARTIs and with medical diagnosis of bronchiolitis or pneumonia.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone metabolism parameters</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Baseline and after 6 months measurement of serum parathormone (PTH), alkaline phosphatases, calcium, phosphorus, and urinary calcium/creatinine ratio.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">276</enrollment>
  <condition>Acute Respiratory Tract Infections</condition>
  <arm_group>
    <arm_group_label>5600 IU Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral 5600 IU Vitamin D3 in liquid weekly during 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral 11200 IU Vitamin D3 weekly</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral 11200 IU Vitamin D3 in liquid weekly during 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral placebo in liquid weekly during 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <arm_group_label>5600 IU Vitamin D3</arm_group_label>
    <arm_group_label>Oral 11200 IU Vitamin D3 weekly</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo liquid</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 18 to 36 months attending daycare in Santiago, Coyhaique or Punta
             Arenas.

        Exclusion Criteria:

          -  History of chronic illness requiring immunosuppression

          -  History of metabolic bone disease

          -  Use of vitamin D supplementation greater than 400 IU daily, either by milk formula or
             vitamin supplements in the last 3 months.

          -  Use of fish oil supplements in the last 3 months.

          -  Immunodeficiency

          -  Planned trip to sunny climate during study period.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>36 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>María L Reyes, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cecilia Vizcaya, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arturo Borzutzky, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Catalina Le Roy, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carlos A. Camargo Jr., M.D. Dr.PH.</last_name>
    <role>Study Director</role>
    <affiliation>Massachusetts General Hospital, Harvard University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karin Brikmann, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Regional de Punta Arenas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Flavia Chamorro, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Hospital de Coyhaique</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Reyes, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Hospital de Coyhaique</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carolina Loureiro, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Pontificia Universidad Catolica de Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>María L Reyes, M.D.</last_name>
    <phone>+56223543753</phone>
    <email>mlreyes@med.puc.cl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cecilia Vizcaya, M.D.</last_name>
    <phone>+56223543753</phone>
    <email>ceciliavizcaya@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Coyhaique</name>
      <address>
        <city>Coyhaique</city>
        <state>Aysen</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Punta Arenas</name>
      <address>
        <city>Punta Arenas</city>
        <state>Magallanes</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Brikmann, M.D.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pontificia Universidad Católica de Chile</name>
      <address>
        <city>Santiago</city>
        <state>Región Metropolitana</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María L. Reyes, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Carolina Loureiro, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sylvia Lopez, R.N.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Las Higueras</name>
      <address>
        <city>Talcahuano</city>
        <state>VIII Región</state>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Campos, M.D.</last_name>
      <email>lauracampos720@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Mónica Arancibia, M.D.</last_name>
      <email>marancibiac@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Laura Campos, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mónica Arancibia, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 29, 2014</lastchanged_date>
  <firstreceived_date>January 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute respiratory tract infections</keyword>
  <keyword>vitamin D</keyword>
  <keyword>cholecalciferol</keyword>
  <keyword>children</keyword>
  <keyword>bronchiolitis</keyword>
  <keyword>pneumonia</keyword>
  <keyword>prevention</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Tract Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
